Can IgE help with allergy?

IgE (Immunoglobulin E) is a central player in type I (immediate) allergic reactions. It binds to allergens and triggers mast cell and basophil degranulation, releasing histamine and other inflammatory mediators. Clinically, IgE is measured in two forms: total IgE and allergen-specific IgE. Total IgE is non-specific and can be elevated in parasitic infections, autoimmune diseases, or certain immunodeficiencies. Specific IgE against particular allergens (e.g., pollen, foods) is a well-established biomarker for sensitization. However, sensitization does not equal clinical allergy – many individuals have specific IgE without symptoms. The evidence for IgE's role in allergy is strong (human-strong), based on decades of clinical research, randomized trials of anti-IgE therapies (e.g., omalizumab), and epidemiological data. Yet IgE alone is neither necessary nor sufficient for allergy diagnosis; history and provocation tests remain the gold standard. Genetic factors, such as variants in FCER1A or IL4, influence IgE levels, but their clinical utility is moderate. For consumer DNA tests, a SNP associated with IgE does not predict allergy. In summary, IgE helps in allergy diagnostics but is only one piece of the puzzle.